| DAA1311 |
RIKEN cDNA 2310033P09 gene |
Molecular |
hematological system |
Mouse |
2310033P09Rik |
1.0% Decrease Gene Expression Level |
|
| DAA1386 |
RIKEN cDNA 1810044D09 gene |
Molecular |
hematological system |
Mouse |
1810044D09Rik |
4.0% Increase Gene Expression Level |
|
| DAA1360 |
RIKEN cDNA 1700006E09 gene |
Molecular |
hematological system |
Mouse |
1700006E09Rik |
88.0% Increase Gene Expression Level |
|
| DAA1314 |
RIKEN cDNA 1600029I14 gene |
Molecular |
hematological system |
Mouse |
1600029I14Rik |
16.0% Increase Gene Expression Level |
|
| DAA1313 |
RIKEN cDNA 1500001M20 gene |
Molecular |
hematological system |
Mouse |
1500001M20Rik |
8.0% Decrease Gene Expression Level |
|
| DAA932 |
Renewal capacity declines |
Physiological |
hematopoietic stem cells |
Human |
— |
— |
|
| DAA2015 |
Regulation of the acid-base equilibrium of the blood unchanged |
Physiological |
blood |
Human |
— |
— |
|
| DAA702 |
Ratio of oxidized to unoxidized plasma albumin increases |
Physiological |
plasma |
Human |
— |
— |
|
| DAA1330 |
Rab40b, member RAS oncogene family |
Molecular |
hematological system |
Mouse |
Rab40b |
18.0% Increase Gene Expression Level |
|
| DAA1339 |
protocadherin beta 21 |
Molecular |
hematological system |
Mouse |
Pcdhb21 |
75.0% Increase Gene Expression Level |
|
| DAA2447 |
protein kinase N1 isoform 2 increases with age |
Molecular |
mesenchymal stem cell |
Human |
PKN1 |
27.7% Increase DNA Methylation |
|
| DAA2446 |
protein kinase C binding protein 1 isoform a increases with age |
Molecular |
mesenchymal stem cell |
Human |
ZMYND8 |
19.9% Increase DNA Methylation |
|
| DAA677 |
Proportion of apoptotic cells may be increased |
Physiological |
mesenchymal stem cell |
Human |
TP53 |
— |
|
| DAA1342 |
pro-platelet basic protein |
Molecular |
hematological system |
Mouse |
Ppbp |
27.0% Decrease Gene Expression Level |
|
| DAA676 |
Proliferation rate of mesenchymal stem cells is reduced |
Physiological |
mesenchymal stem cell |
Human |
— |
— |
|
| DAA920 |
Prolactin increases in males |
Physiological |
plasma |
Human |
— |
— |
|
| DAA2022 |
Prolactin decreases in females |
Physiological |
plasma |
Human |
— |
— |
|
| DAA935 |
Pro-B cell generation and differentiation declines |
Physiological |
bone marrow, B cell |
Human |
— |
— |
|
| DAA1347 |
pleckstrin homology-like domain, family B, member 2 |
Molecular |
hematological system |
Mouse |
Phldb2 |
8.0% Decrease Gene Expression Level |
|
| DAA917 |
Plasma and urinary catecholamine elevation after stimuli |
Physiological |
plasma |
Human |
— |
— |
|
| DAA1354 |
periostin, osteoblast specific factor |
Molecular |
hematological system |
Mouse |
Postn |
39.0% Decrease Gene Expression Level |
|
| DAA2456 |
PDZ and LIM domain 2 isoform 3 increases with age |
Molecular |
mesenchymal stem cell |
Human |
PDLIM2 |
43.9% Increase DNA Methylation |
|
| DAA1312 |
paired-like homeodomain transcription factor 2 |
Molecular |
hematological system |
Mouse |
Pitx2 |
17.0% Decrease Gene Expression Level |
|
| DAA701 |
Oxidative increase in cystine/cysteine ratio |
Physiological |
plasma |
Human |
— |
— |
|
| DAA1959 |
Osteoblast differentiation decreases |
Physiological |
bone marrow |
Mouse |
— |
— |
|